MedPath

Selective Laser Trabeculoplasty for Primary Angle-Closure Glaucoma: a pilot case study

Completed
Conditions
Primary angle-closure glaucoma
Eye Diseases
Glaucoma
Registration Number
ISRCTN42557387
Lead Sponsor
Ellex Medical Pty. Ltd. (Australia)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. PACG
2. Intraocular pressure 21 - 28 mmHg on one or more topical medicine in presence of patent iridotomy
3. At least two months since last iridotomy
4. Aged over 21 years old

Exclusion Criteria

1. Secondary causes of angle-closure
2. Corneal abnormalities
3. Advanced glaucomatous optic neuropathy
4. Patient blind in one eye

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intraocular pressure (IOP) at regular intervals of follow-up with the final IOP being measured at six months after the last treatment. Successful outcome defined as greater or equal to 20% reduction in IOP from pre-laser levels.
Secondary Outcome Measures
NameTimeMethod
IOP measured on other eye if both eyes are eligible for the study.
© Copyright 2025. All Rights Reserved by MedPath